Presentations

13:45

Is there still a role for anti IL-6R in ABMR treatment?

Roslyn B. Mannon (US)

Bio

14:05

Is anti-CD38 the most promising agent for ABMR?

Katharina Mayer (AT)

Bio

14:25

What does monitoring AUC add compared to C-trough only?

Teun van Gelder (NL)

Bio

14:45

Model Informed precision dosing

Anders Asberg (NO)

Bio